Grants per year
- 25 - 43 out of 43 results
Search results
-
Finished
Prot# IM103008: Belatacept Evaluation of Nephroprotection and Efficacy as First-Line Immunosuppression Trial (BENEFIT)
Abecassis, M. M. (Co-PD/PI), Baker, T. B. (Co-PD/PI), Friedewald, J. J. (Co-PD/PI), Fryer, J. P. (Co-PD/PI), Gallon, L. (Co-PD/PI), Leventhal, J. R. (Co-PD/PI) & Luo, X. (Co-PD/PI)
ICON Clinical Research, LLC, Bristol-Myers Squibb Company
11/2/06 → 9/24/10
Project: Research project
-
Prot# ISA05-01: A Phase IIB, Randomized, Multicenter, Open-Label, Concentration-Controlled, Safety Study of ISA247 and Tacrolimus (Prograf®) in De Novo Renal Transplant Patients
Leventhal, J. R. (PD/PI), Abecassis, M. M. (Co-PD/PI), Baker, T. B. (Co-PD/PI), Friedewald, J. J. (Co-PD/PI), Fryer, J. P. (Co-PD/PI), Gallon, L. (Co-PD/PI) & Luo, X. (Co-PD/PI)
CTI Clinical Trial and Consulting Services, Isotechnika Inc.
6/27/06 → 1/12/10
Project: Research project
-
Prot# ISA05-01: A Phase IIB, Randomized, Multicenter, Open-Label, Concentration-Controlled, Safety Study of ISA247 and Tacrolimus (Prograf®) in De Novo Renal Transplant Patients
Leventhal, J. R. (PD/PI), Abecassis, M. M. (Co-PD/PI), Baker, T. B. (Co-PD/PI), Friedewald, J. J. (Co-PD/PI), Fryer, J. P. (Co-PD/PI), Gallon, L. (Co-PD/PI) & Luo, X. (Co-PD/PI)
CTI Clinical Trial and Consulting Services, Isotechnika Inc.
6/27/06 → 1/12/10
Project: Research project
-
Prot# A3921021: Mltctr, Phase 2, Opn-Lbl, Controlled, Extension Study for Stage 1 Subjects of Study A3921009 to Evaluate Long-Term Safety & Efficacy of CP-690,550 vs. Tacrolimus, When Co-Administered w/ Mycophenolate Mofetil in Renal Allograft Recipients
Leventhal, J. R. (PD/PI), Friedewald, J. J. (Co-PD/PI) & Gallon, L. (Co-PD/PI)
12/12/05 → 9/1/14
Project: Research project
-
Prot# 20-04-003: Phz 4, Rndmzd, Opn-Lbl, Cmprtv, Mltctr Study to Assess S&E of Induction Agents Alemtuzumab(Campath 1H), Basiliximab(Simulect) or Rabbit Anti-Thymocyte Globulin(Thymoglobulin) in Combt'n w/Tacrolimus(Prograf), Mycophenolate Mofetil(Cellcep
Friedewald, J. J. (Co-PD/PI), Gallon, L. (Co-PD/PI) & Leventhal, J. R. (Co-PD/PI)
9/19/05 → 12/31/09
Project: Research project
-
Prot# IM103027: Belatacept Evaluation of Nephroprotection and Efficacy as First-Line Immunosuppression Trial -- Extended Criteria Donors (BENEFIT-EXT) [Phase 3, Randomized, Partially-Blinded, Active-Controlled, Parallel-Group, Multicenter Clinical Trial]
Gallon, L. (PD/PI), Abecassis, M. M. (Co-PD/PI), Baker, T. B. (Co-PD/PI), Gallon, L. (Co-PD/PI) & Leventhal, J. R. (Co-PD/PI)
ICON Clinical Research, LLC, Bristol-Myers Squibb Company
6/15/05 → 12/1/14
Project: Research project
-
Prot# A3921009: 6-Mnth, Phz 2, Mltctr, Rndmzd, Opn-Lbl, Cmp'tv Study of 2 Dose Levels of CP-690,550 Admin'd Concomitantly w/ IL-2 Receptor Antagonist Induction Therapy, Mycophenolate Mofetil & Corticosteroids vs Tacrolimus-Based Immunosuppressive Regimen
Leventhal, J. R. (PD/PI), Abecassis, M. M. (Co-PD/PI), Baker, T. B. (Co-PD/PI), Fryer, J. P. (Co-PD/PI) & Gallon, L. (Co-PD/PI)
CTI Clinical Trial and Consulting Services, Pfizer Inc.
6/13/05 → 1/12/10
Project: Research project
-
Prot# CEL220: A Phase IV, Single Center Pilot Study Using Alemtuzumab (CAMPATH-1H) Induction Combined with Prednisone-Free and Calcineurin-Inhibitor-Free Immunosuppression in Kidney Transplantation
Leventhal, J. R. (PD/PI) & Gallon, L. (Co-PD/PI)
1/25/05 → 11/1/11
Project: Research project
-
Piscine Islet Transplantation for Treatment of Diabetes: A Pilot Study in Non-Human Primates
Leventhal, J. R. (PD/PI)
Northwestern Memorial Foundation
1/1/05 → 12/31/05
Project: Research project
-
Piscine Islet Transplantation for Treatment of Diabetes: A Pilot Study in Non-Human Primates
Leventhal, J. R. (PD/PI)
Northwestern Memorial Foundation
1/1/05 → 12/31/05
Project: Research project
-
Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT): A Randomized, Controlled Clinical Trial of the Effect of a High Dose Combination of Folic Acid, Vitamin B6 and Vitamin B12, on Arteriosclerotic Cardiovascular Disease Outcomes in Chro
Gallon, L. (PD/PI), Abecassis, M. M. (Co-PD/PI) & Leventhal, J. R. (Co-PD/PI)
Rhode Island Hospital, National Institute of Diabetes and Digestive and Kidney Diseases
10/1/04 → 1/31/09
Project: Research project
-
Desensitization of Cross Match Positive Renal Transplant Recipients Using Alemtuzumab: An Investigator Initiated Proposal (ICAM085)
Leventhal, J. R. (PD/PI) & Gallon, L. (Co-PD/PI)
8/20/04 → 1/14/10
Project: Research project
-
Desensitization of Cross Match Positive Renal Transplant Recipients Using Alemtuzumab: An Investigator Initiated Proposal (ICAM085)
Leventhal, J. R. (PD/PI) & Gallon, L. (Co-PD/PI)
8/20/04 → 1/14/10
Project: Research project
-
CD4+CD25+ Regulatory T Cells as Cellular Therapy for Prevention of Kidney Allograft Rejection
Leventhal, J. R. (PD/PI) & Zhang, Z. J. (Co-PD/PI)
National Kidney Foundation of Illinois
7/1/04 → 6/30/06
Project: Research project
-
Prot# CRAD001A US09: A Prospective, Multicenter, Open-Label, Randomized Study of Safety, Tolerability & Efficacy of Certican® (RAD001) w/ Simulect®, Corticosteroids & Lower Levels Versus Higher Levels of Tacrolimus in de novo Renal Transplant Recipients
Abecassis, M. M. (PD/PI), Gallon, L. (Co-PD/PI) & Leventhal, J. R. (Co-PD/PI)
Novartis Pharmaceuticals Corporation
10/17/03 → 4/30/05
Project: Research project
-
A Single Center, Open-Label Study of Rapid Corticosteroid Withdrawal in Kidney Transplantation: A Randomized Trial of Sirolimus vs Mycophenolate Mofetil in Transplant Recipients Receiving Tacrolimus-Based Immunotherapy (Study# KAB-00-001)
Abecassis, M. M. (Co-PD/PI), Fryer, J. P. (Co-PD/PI) & Leventhal, J. R. (Co-PD/PI)
9/20/00 → 8/7/09
Project: Research project
-
A Single Center, Open-Label Study of Rapid Corticosteroid Withdrawal in Kidney Transplantation: A Randomized Trial of Sirolimus vs Mycophenolate Mofetil in Transplant Recipients Receiving Tacrolimus-Based Immunotherapy (Study# KAB-00-001)
Abecassis, M. M. (Co-PD/PI), Fryer, J. P. (Co-PD/PI) & Leventhal, J. R. (Co-PD/PI)
9/20/00 → 8/7/09
Project: Research project
-
Protocol # ZEN049: Trial of 2 Daclizumab Dosing Strategies versus No Induction Treatment with Tacrolimus, Mycophenolate Mofetil and Steroids for Prevention of Acute Allograft Rejection in Simultan Kidney/Pancreas Transplant Recipients
Abecassis, M. M. (Co-PD/PI), Fryer, J. P. (Co-PD/PI) & Leventhal, J. R. (Co-PD/PI)
University of Tennessee Health Science Center, Roche Bioscience
1/1/99 → 11/21/06
Project: Research project